Pharmacological Evaluation of New 4, 5-dihydro-1H- Pyrazole-1-yl acetate Derivatives as anti-cancer agents
A series of nine novel 4, 5-dihydro-1H- pyrazole-1-yl acetate derivatives (IVa-i) by Shahlaa et al. was investigated in vitro for their antiproliferative activity against two cancer cell lines, breast cancer cell line (MCF-7) and lung cancer cell lines (A549), According to the cytotoxicity...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
College of Pharmacy / Mustansiriyah University
2023-01-01
|
| Series: | Al-Mustansiriyah Journal of Pharmaceutical Sciences |
| Subjects: | |
| Online Access: | https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/963 |
| _version_ | 1797223913689710592 |
|---|---|
| author | Shahlaa Zuhair Abdul-Majeed Monther Faisal Mahdi Suhad Faisal Hatem Al-Mugdadi |
| author_facet | Shahlaa Zuhair Abdul-Majeed Monther Faisal Mahdi Suhad Faisal Hatem Al-Mugdadi |
| author_sort | Shahlaa Zuhair Abdul-Majeed |
| collection | DOAJ |
| description |
A series of nine novel 4, 5-dihydro-1H- pyrazole-1-yl acetate derivatives (IVa-i) by Shahlaa et al. was investigated in vitro for their antiproliferative activity against two cancer cell lines, breast cancer cell line (MCF-7) and lung cancer cell lines (A549), According to
the cytotoxicity effect of these compounds, IVa, IVc and IVi compounds have antiproliferative effect with percentage (81.30%, 87.4% & 54.66%) respectively at 72h treatment on MCF-7 cell line compared to other compounds, these results indicate that the new compound IVc have the higher antiproliferative percent comparable to tamoxifen as a standard anti-tumour for oestrogen receptor positive breast cancer cell line after 72h followed by IVa after 72h (83.31%). cytotoxicity effect of compound IVb was highest among tested compounds on lung cancer cell line (A549) with antiproliferative percentage (58.49% & 75.04%) at 48 & 72h respectively, but it is less than erlotinib as a standard anti-tumour for lung cancer cell line cytotoxicity effect (77.10% & 82.46%) at these times. three compounds (IVa, IVc & IVi) have antiproliferative effect on breast cancerous cell line (MCF-7) and compound (IVc) have inhibition percentage comparable to that of the authorized medication Tamoxifen. One compound (IVb) had antiproliferative activity, but less than that of erlotinib on lung cancerous cell line (A549) and there is good agreement between our docking results and the experimental results.
|
| first_indexed | 2024-04-24T13:44:47Z |
| format | Article |
| id | doaj.art-3a037611ce304c52980a4ec19d2d05fa |
| institution | Directory Open Access Journal |
| issn | 1815-0993 2959-183X |
| language | English |
| last_indexed | 2024-04-24T13:44:47Z |
| publishDate | 2023-01-01 |
| publisher | College of Pharmacy / Mustansiriyah University |
| record_format | Article |
| series | Al-Mustansiriyah Journal of Pharmaceutical Sciences |
| spelling | doaj.art-3a037611ce304c52980a4ec19d2d05fa2024-04-04T06:56:21ZengCollege of Pharmacy / Mustansiriyah UniversityAl-Mustansiriyah Journal of Pharmaceutical Sciences1815-09932959-183X2023-01-0122410.32947/ajps.v22i4.963Pharmacological Evaluation of New 4, 5-dihydro-1H- Pyrazole-1-yl acetate Derivatives as anti-cancer agentsShahlaa Zuhair Abdul-Majeed0Monther Faisal Mahdi1Suhad Faisal Hatem Al-Mugdadi2Department of Pharmaceutical Chemistry, College of pharmacy, Mustansiriyah University, Baghdad, IraqDepartment of Pharmaceutical Chemistry, College of pharmacy, Mustansiriyah University, Baghdad, IraqDepartment of Clinical Laboratory science, College of pharmacy, Mustansiriyah University, Baghdad, Iraq A series of nine novel 4, 5-dihydro-1H- pyrazole-1-yl acetate derivatives (IVa-i) by Shahlaa et al. was investigated in vitro for their antiproliferative activity against two cancer cell lines, breast cancer cell line (MCF-7) and lung cancer cell lines (A549), According to the cytotoxicity effect of these compounds, IVa, IVc and IVi compounds have antiproliferative effect with percentage (81.30%, 87.4% & 54.66%) respectively at 72h treatment on MCF-7 cell line compared to other compounds, these results indicate that the new compound IVc have the higher antiproliferative percent comparable to tamoxifen as a standard anti-tumour for oestrogen receptor positive breast cancer cell line after 72h followed by IVa after 72h (83.31%). cytotoxicity effect of compound IVb was highest among tested compounds on lung cancer cell line (A549) with antiproliferative percentage (58.49% & 75.04%) at 48 & 72h respectively, but it is less than erlotinib as a standard anti-tumour for lung cancer cell line cytotoxicity effect (77.10% & 82.46%) at these times. three compounds (IVa, IVc & IVi) have antiproliferative effect on breast cancerous cell line (MCF-7) and compound (IVc) have inhibition percentage comparable to that of the authorized medication Tamoxifen. One compound (IVb) had antiproliferative activity, but less than that of erlotinib on lung cancerous cell line (A549) and there is good agreement between our docking results and the experimental results. https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/963Pyrazole, anticancer, 4, 5-dihydro-1H- Pyrazole, MCF-7, A549 |
| spellingShingle | Shahlaa Zuhair Abdul-Majeed Monther Faisal Mahdi Suhad Faisal Hatem Al-Mugdadi Pharmacological Evaluation of New 4, 5-dihydro-1H- Pyrazole-1-yl acetate Derivatives as anti-cancer agents Al-Mustansiriyah Journal of Pharmaceutical Sciences Pyrazole, anticancer, 4, 5-dihydro-1H- Pyrazole, MCF-7, A549 |
| title | Pharmacological Evaluation of New 4, 5-dihydro-1H- Pyrazole-1-yl acetate Derivatives as anti-cancer agents |
| title_full | Pharmacological Evaluation of New 4, 5-dihydro-1H- Pyrazole-1-yl acetate Derivatives as anti-cancer agents |
| title_fullStr | Pharmacological Evaluation of New 4, 5-dihydro-1H- Pyrazole-1-yl acetate Derivatives as anti-cancer agents |
| title_full_unstemmed | Pharmacological Evaluation of New 4, 5-dihydro-1H- Pyrazole-1-yl acetate Derivatives as anti-cancer agents |
| title_short | Pharmacological Evaluation of New 4, 5-dihydro-1H- Pyrazole-1-yl acetate Derivatives as anti-cancer agents |
| title_sort | pharmacological evaluation of new 4 5 dihydro 1h pyrazole 1 yl acetate derivatives as anti cancer agents |
| topic | Pyrazole, anticancer, 4, 5-dihydro-1H- Pyrazole, MCF-7, A549 |
| url | https://ajps.uomustansiriyah.edu.iq/index.php/AJPS/article/view/963 |
| work_keys_str_mv | AT shahlaazuhairabdulmajeed pharmacologicalevaluationofnew45dihydro1hpyrazole1ylacetatederivativesasanticanceragents AT montherfaisalmahdi pharmacologicalevaluationofnew45dihydro1hpyrazole1ylacetatederivativesasanticanceragents AT suhadfaisalhatemalmugdadi pharmacologicalevaluationofnew45dihydro1hpyrazole1ylacetatederivativesasanticanceragents |